
整合药学杂志(英文)(Journal of Holistic Integrative Pharmacy)(国际刊号)(2026年3月31日前不收版面费审稿费) 知网目次
- 主管单位:
- 主办单位:
广东药科大学、中国整合医学发展战略研究院
- 国际刊号:
2707-3688
- 国内刊号:
- 学科分类:
- 字数:
-
- 有无基金:
- 周期:
国际号刊-季刊
- 特殊属性:
外文期刊
- 电话:
020-39352063(官网电话)
- 邮箱:
hip2063@gdpu.edu.cn(官网邮箱)
- 复合因子:
0
- 综合因子:
0
- 收录:
知网目次
- 级别:
期刊简介
《整合药学杂志》期刊已被查看: 次
更新频次
单位占比
一作占比
投稿指南
1、该刊只有国际刊号。
2、投稿方式:在线投稿。
3、官网网址:https://jhip.gdpu.edu.cn/
https://www.keaipublishing.com/en/journals/journal-of-holistic-integrative-pharmacy/
https://www.sciencedirect.com/journal/journal-of-holistic-integrative-pharmacy/
4、投稿系统:
https://www2.cloud.editorialmanager.com/jhip/default2.aspx
5、出刊日期:季刊,逢季末月出版。
8、微信公众号信息:2026年3月31日前投稿免交APC处理费。
2024年2月29日星期四
《整合药学杂志》英文刊全面启用
Editorial Manager(EM)国际化投审稿系统!
【官网信息】
《整合药学杂志》英文刊全面启用Editorial Manager(EM)国际化投审稿系统!
为更好地服务全球的作者、审稿专家,提高《整合药学杂志》英文刊(Journal of Holistic Integrative Pharmacy,JHIP)的国际化办刊水平,本刊于2023年6月12日正式启用国际化投审稿系统Editorial Manager(EM)(网址:https://www.editorialmanager.com/jhip/default2.aspx),接受来稿并进行稿件同行评议、对接海外排版生产和网刊发布。JHIP主要刊载药学与传统医药、药学与现代医学、药学与现代新兴技术、药学基础研究与应用开发、药学与人文相结合等融汇药学各相关学科方法与知识的论文。
本刊与北京科爱森蓝文化传播有限公司(简称科爱)合作出版,稿件全文在月活用户超1700万的ScienceDirect平台发布,供全球读者免费下载。从2022年第3卷第1期起已正式被美国化学文摘数据库CAS收录。目前同行评议的优质稿件仍有机会获得丰厚的稿酬,免交APC处理费,欢迎广大读者、作者赐稿。
使用过程中如有任何疑问,请随时垂询交流,编辑部电话:020-39352063;邮箱:hip2063@gdpu.edu.cn。
投稿链接:https://www.editorialmanager.com/jhip/default2.aspx
期刊网址:
https://www.keaipublishing.com/en/journals/journal-of-holistic-integrative-pharmacy/
Guide for Authors投稿指南
【官网信息】
INTRODUCTION
Types of paper
Original Research Article
Review Article
Mini review
Short Communication
Editorial
Case report
Guideline/Consensus
Meeting Reports, News and Announcements
Letter to the Editor
Perspective
Others
Original Research Article (Word limit: 3000–8000 words in main text except for special cases approved by the Editors)
Original research article is a complete report on original research and/or clinical studies with enough related tables and/or figures. A structured abstract is required. A clear structure is required, which should contain but not confined to the following sections:
Introduction
Material and methods
Results
Discussion
Conclusions
Ethic statement
Authors' contribution (For details please visit the link.)
Funding
Acknowledgments/clarification
COI
Bibliography
Appendices (including multimedia components)
Details guide to the article structure.
Review Article (Word limit: 4000-12000 words in main text except for special cases approved by the Editors)
A substantial overviews present a complete overview of the state of the art with a comprehensive bibliography, generally, also contains a table of contents. It should cover topics that have seen significant development or progress in recent years, with comprehensive depth and a balanced perspective. Review articles should NOT include unpublished material such as unpublished/original data, submitted manuscripts, or personal communication.
Mini review(Word limit: 3000-5000 words)
A succinct and clear summary that covers focused aspects of a current area of investigation and its recent developments, providing up–to–date developments, concepts, etc.
Short Communication (Word limit: 2000-4000 words)
Short report or announcement of research, usually claiming certain results, which present original and significant material for rapid dissemination. Short Communications are expected to have a higher than average impact on the field rather than report on incremental research.
Editorial (Word limit: 3000)
Generally from the (guest) editor of the publication. Can be Foreword, Editorial, Guest Editorial, Preface, etc.
Case Report (Word limit: 3000)
Case Reports (CR) are brief reports of individual patients or small cohorts reporting novel findings of unexpected clinical significance. They are peer-reviewed articles under xxx words in length. Methods and additional figures and display items may be included in the Supplementary Information.
Guideline/Consensus (Word limit: 9000) (for clinical medicine only)
Guidelines: Documents that have been locally or internationally approved and contain general principles that may benefit others in their clinical practice or in writing their own guidelines. Consensus: Evidence-based analyses of issues that integrate findings, ideas and/or conceptual frameworks from a variety of sources in a clear and balanced way.
Meeting Reports, News and Announcements (Word limit: 3500)
Meeting reports Summary of a relevant symposium, workshop, etc. Or, information about a conference (can be a description of the venture, but also a visit report of a scientist who has attended a conference).
Letter to the Editorial (Word limit: 2,000)
Any items of interest to the wide audience of the publication. The items include a letter to the editor commenting on previously published articles or a reply to the letter. (The letter o
……
更多详情:
https://www.keaipublishing.com/en/journals/journal-of-holistic-integrative-pharmacy/guide-for-authors/
上一篇:血管研究与治疗(英文)(Vascular Investigation and Therapy)(OA学术期刊)(国际刊号)下一篇:音乐世界
《整合药学杂志》同类药学期刊
-
药学学报
北核,CSCD,科核,武A+
CN中文-月刊影响因子2.553
-
中国新药杂志
北核,CSCD,科核,武A
CN中文-半月刊影响因子1.443
-
中国药学杂志
北核,CSCD,科核,武A-
CN中文-半月刊影响因子1.392
-
中国药理学通报
北核,CSCD,科核,武A+
CN中文-月刊影响因子2.322
-
中国抗生素杂志
北核,CSCD,科核,武A-
CN中文-月刊影响因子1.596
-
中国临床药理学杂志
北核,CSCD,科核,武A+
CN中文-半月刊影响因子1.499
-
中国药理学与毒理学杂志(不收版面费审稿费)
北核,科核,武A
CN中文-月刊影响因子1.087
-
中国药房
北核,科核,武A
CN中文-半月刊影响因子2.197
常见问题
-
整合药学杂志杂志社官网、联系方式是什么?
整合药学杂志杂志社官网:https://jhip.gdpu.edu.cn/
投稿网址:https://www2.cloud.editorialmanager.com/jhip/default2.aspx联系电话:020-39352063(官网电话)
投稿邮箱:hip2063@gdpu.edu.cn(官网邮箱) -
整合药学杂志杂志是核心期刊么?
整合药学杂志不是核心期刊,级别是:, 是:药学分类下的知网目次收录的期刊。
-
请问你们是整合药学杂志杂志社吗?
我们不是《整合药学杂志》杂志社。本站主要从事期刊信息展示与期刊推荐,不是任何杂志官网,直投稿件请联系杂志社。本站仅提供免费的学术指导、论文辅导、期刊投稿信息整理收集服务。
-
你们指导服务后可以保证文章被发表吗?
期刊发表的成功与否,主要取决于文章内容的质量。编辑老师会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。
-
晋级论文能否在报纸上发表?
在学术界,论文的发表往往被视为研究者职业发展的重要一环。晋级论文,即为了获得更高职称或学术地位而撰写的学术论文,通常需在专业期刊上发表。然而,许多人可能会问